Burn wound itch control using H1 and H2 antagonists

Area of Science:

• Dermatology
• Pharmacology

Background:

• Burn wound pruritus (itch) is a common and distressing symptom.
• Effective management of burn itch is crucial for patient comfort and healing.

Purpose of the Study:

• To evaluate the efficacy of a combination of H1 and H2 antagonists versus placebo in controlling burn wound itch.
• To compare cetirizine/cimetidine with diphenhydramine/placebo for itch relief.

Main Methods:

• A 16-day study using a Graeco-Latin square design.
• Participants received either cetirizine/cimetidine or diphenhydramine/placebo orally.
• Itch severity was scored at baseline and at 1, 6, and 12 hours post-medication.

Main Results:

• A significant difference in mean itch scores was observed over time.
• The cetirizine/cimetidine combination showed dramatic itch improvement at 1 and 6 hours, and moderate improvement at 12 hours.
• A distinct itch pattern was noted in the initial days of the study.

Conclusions:

• The combination of cetirizine and cimetidine is more effective than diphenhydramine/placebo in managing burn wound itch.
• Oral H1 and H2 antagonist combinations represent a promising strategy for burn pruritus control.